Oncotarget

Research Papers:

SSeCKS/AKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL9/10 secretion by resident fibroblasts

Masashi Muramatsu, Lingqiu Gao, Jennifer Peresie, Benjamin Balderman, Shin Akakura and Irwin H. Gelman _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:70281-70298. https://doi.org/10.18632/oncotarget.20092

Metrics: PDF 2220 views  |   HTML 2675 views  |   ?  


Abstract

Masashi Muramatsu1, Lingqiu Gao2, Jennifer Peresie2, Benjamin Balderman2, Shin Akakura3 and Irwin H. Gelman2

1Institute of Resource Development and Analysis, Kumamoto University, Kumamoto 860-0811, Japan

2Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo 14263, NY, USA

3Frontiers in Bioscience Research Institute in Aging and Cancer, Irvine 92618, CA, USA

Correspondence to:

Irwin H. Gelman, email: [email protected]

Keywords: SSeCKS/AKAP12, metastasis, senescent secretome, CXCL9/10, CXCR3

Received: June 09, 2017     Accepted: July 26, 2017     Published: August 09, 2017

ABSTRACT

SSeCKS/Gravin/AKAP12 (SSeCKS) is a kinase scaffolding protein known to suppress metastasis by attenuating tumor-intrinsic PKC- and Src-mediated signaling pathways [1]. In addition to downregulation in metastatic cells, in silico analyses identified SSeCKS downregulation in prostate or breast cancer-derived stroma, suggesting a microenvironmental cell role in controlling malignancy. Although orthotopic B16F10 and SM1WT1[BrafV600E] mouse melanoma tumors grew similarly in syngeneic WT or SSeCKS-null (KO) mice, KO hosts exhibited 5- to 10-fold higher levels of peritoneal metastasis, and this enhancement could be adoptively transferred by pre-injecting naïve WT mice with peritoneal fluid (PF), but not non-adherent peritoneal cells (PC), from naïve KO mice. B16F10 and SM1WT1 cells showed increased chemotaxis to KO-PF compared to WT-PF, corresponding to increased PF levels of multiple inflammatory mediators, including the Cxcr3 ligands, Cxcl9 and 10. Cxcr3 knockdown abrogated enhanced chemotaxis to KO-PF and peritoneal metastasis in KO hosts. Conditioned media from KO peritoneal membrane fibroblasts (PMF), but not from KO-PC, induced increased B16F10 chemotaxis over controls, which could be blocked with Cxcl10 neutralizing antibody. KO-PMF exhibited increased levels of the senescence markers, SA-β-galactosidase, p21waf1 and p16ink4a, and enhanced Cxcl10 secretion induced by inflammatory mediators, lipopolysaccharide, TNFα, IFNα and IFNγ. SSeCKS scaffolding-site mutants and small molecule kinase inhibitors were used to show that the loss of SSeCKS-regulated PKC, PKA and PI3K/Akt pathways are responsible for the enhanced Cxcl10 secretion. These data mark the first description of a role for stromal SSeCKS/AKAP12 in suppressing metastasis, specifically by attenuating signaling pathways that promote secretion of tumor chemoattractants in the peritoneum.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20092